ACT Dry Mouth Mouthwash, Lozenges
September 28th, 2018
The National Advertising Division (aka NAD) takes a more nuanced approach. The self-regulatory body, which just held its annual conference in New York City this week, recommends changes and it’s up to the advertiser to decide whether it wants to follow those recommendations or appeal them.
Recently, when faced with those two options, the marketer of ACT Dry Mouth products chose the latter.
Chattem said it would appeal recommendations by NAD that it discontinue claims that ACT Dry Mouth mouthwash “provides immediate, long-lasting relief” and “soothes dry mouth,” and that ACT Dry Mouth lozenges are uniquely formulated to stimulate saliva flow and soothe and moisturize dry mouth. NAD said a study provided by Chattem supported claims that the mouthwash “moisturizes dry mouth.” The advertising at issue was challenged by GlaxoSmithKline, maker of competing Biotene oral care products.
NAD defined dry mouth as “a broad term that can refer to a wide range of symptoms including fleeting dryness associated with eating salty foods or drinking alcohol, but also sustained oral dryness caused by prescription medications or chronic disease. More advanced symptoms can lead to serious health problems such as difficulty tasting or chewing, oral discomfort, and increased chance of tooth decay or infection.”
According to Chattem, dry mouth affects 10 percent of all adults and 25 percent of those over 65.
Find more of our coverage on oral care products here.
The National Advertising Division, or NAD, is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus. NAD asks advertisers to substantiate or change their claims in advertisements. As part of a voluntary system of self-regulation, however, its recommendations can be ignored by the offending advertisers. In those instances, NAD refers the offender to federal consumer protection agencies.